search
Back to results

A Randomised Trial Comparing Anterior Versus Posterior Approach in Total Hip Replacement

Primary Purpose

Osteoarthritis, Rheumatoid Arthritis

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Minimally Invasive Anterior Approach
Standard postero-lateral approach
Sponsored by
Medacta International SA
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Males and females aged 18-75 years at time of surgery.
  • Those presenting with primary or secondary osteoarthritis and/or rheumatoid arthritis of the hip.
  • Those deemed capable of giving informed consent, understanding the aims of the study and expressing willingness to comply with the post-operative review programme.
  • Patients who signed the study consent form prior to surgery.

Exclusion Criteria:

  • Pregnant women or women who plan to conceive in the future.
  • Those whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems.
  • Those already treated by with a Total Hip Replacement (THR) (i.e. requiring a revision hip replacement).
  • Those with co-existent ipsilateral knee disease or back problems
  • Muscle contracture around the hip joint
  • Individuals who have undergone organ transplant.
  • Those with a known co-existent medical condition where death is anticipated within five years due to the pre-existing medical condition.
  • Individuals who have had a THR on the contra-lateral side within the 6 months.
  • Individuals who have undergone a THR on the contralateral side and whose outcome is considered unsatisfactory or not good. An unsatisfactory or poor result is defined as achieving a total UCLA score (including activity) < 16 points.
  • Individuals requiring bilateral hip replacement.
  • Individuals whose body mass index (BMI; kg/m2) >35.
  • Individuals with active or suspected infection or sepsis.
  • Individuals with renal failure and/or renal insufficiency.
  • Patients with severe forms of developmental dysplasia of the hip (DDH): Crowe types II, III, IV.

Sites / Locations

  • The Elective Orthopaedic Centre (EOC)

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Anterior Approach Group

Posterior Approach Group

Arm Description

(AMIS)

(Posterior)

Outcomes

Primary Outcome Measures

Compare gait kinematics and the return to normalization of gait in patients that have undergone a THA via the direct anterior approach vs. the posterior approach

Secondary Outcome Measures

Clinical assessment of patient using the Harris Hip Score
Assessment of the improvement in quality of life and joint movement using the EuroQol-5D Score
Assessment of patient's level of activity using the UCLA score
Radiological evaluation to assess the fixation and stability of femoral and acetabular components
Strength Testing
Muscle strength will be assessed using the MIE digital myometer (from patient #50 to patient #100)
MRI evaluation
A MRI examination will be used to detect any damage in the hip musculature and tendons (from patient #50 to patient #100)
Assessment of gait kinematics
Comparison gait analysis Anterior vs Posterior groups at fixed time point (from patient #50 to patient # 100)

Full Information

First Posted
April 15, 2010
Last Updated
April 11, 2016
Sponsor
Medacta International SA
search

1. Study Identification

Unique Protocol Identification Number
NCT01106560
Brief Title
A Randomised Trial Comparing Anterior Versus Posterior Approach in Total Hip Replacement
Official Title
A Single Centre Prospective Randomised Controlled Clinical Trial Comparing Total Hip Arthroplasty Performed Either Through a Posterior Approach or a Direct Anterior Approach
Study Type
Interventional

2. Study Status

Record Verification Date
April 2015
Overall Recruitment Status
Completed
Study Start Date
January 2010 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
December 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medacta International SA

4. Oversight

5. Study Description

Brief Summary
This is a single-centre, randomised, prospective clinical follow-up study to evaluate clinical outcome and gait analysis after total hip arthroplasty using the standard postero-lateral approach or the minimally invasive anterior approach.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Osteoarthritis, Rheumatoid Arthritis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Anterior Approach Group
Arm Type
Active Comparator
Arm Description
(AMIS)
Arm Title
Posterior Approach Group
Arm Type
Active Comparator
Arm Description
(Posterior)
Intervention Type
Procedure
Intervention Name(s)
Minimally Invasive Anterior Approach
Intervention Description
Anterior minimally invasive surgery (AMIS)
Intervention Type
Procedure
Intervention Name(s)
Standard postero-lateral approach
Primary Outcome Measure Information:
Title
Compare gait kinematics and the return to normalization of gait in patients that have undergone a THA via the direct anterior approach vs. the posterior approach
Time Frame
on average up to 6 weeks
Secondary Outcome Measure Information:
Title
Clinical assessment of patient using the Harris Hip Score
Time Frame
pre-op and 6 weeks, 6 months, 1 year after surgery
Title
Assessment of the improvement in quality of life and joint movement using the EuroQol-5D Score
Time Frame
pre-op, 1 year post-op
Title
Assessment of patient's level of activity using the UCLA score
Time Frame
pre-op and 6 weeks, 6 months, 1 year after surgery
Title
Radiological evaluation to assess the fixation and stability of femoral and acetabular components
Time Frame
pre-op and 6 weeks, 6 months, 1 year after surgery
Title
Strength Testing
Description
Muscle strength will be assessed using the MIE digital myometer (from patient #50 to patient #100)
Time Frame
6 weeks, 6 months and 1y after surgery
Title
MRI evaluation
Description
A MRI examination will be used to detect any damage in the hip musculature and tendons (from patient #50 to patient #100)
Time Frame
preop-1y after surgery
Title
Assessment of gait kinematics
Description
Comparison gait analysis Anterior vs Posterior groups at fixed time point (from patient #50 to patient # 100)
Time Frame
6 weeks, 12 weeks and 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Males and females aged 18-75 years at time of surgery. Those presenting with primary or secondary osteoarthritis and/or rheumatoid arthritis of the hip. Those deemed capable of giving informed consent, understanding the aims of the study and expressing willingness to comply with the post-operative review programme. Patients who signed the study consent form prior to surgery. Exclusion Criteria: Pregnant women or women who plan to conceive in the future. Those whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems. Those already treated by with a Total Hip Replacement (THR) (i.e. requiring a revision hip replacement). Those with co-existent ipsilateral knee disease or back problems Muscle contracture around the hip joint Individuals who have undergone organ transplant. Those with a known co-existent medical condition where death is anticipated within five years due to the pre-existing medical condition. Individuals who have had a THR on the contra-lateral side within the 6 months. Individuals who have undergone a THR on the contralateral side and whose outcome is considered unsatisfactory or not good. An unsatisfactory or poor result is defined as achieving a total UCLA score (including activity) < 16 points. Individuals requiring bilateral hip replacement. Individuals whose body mass index (BMI; kg/m2) >35. Individuals with active or suspected infection or sepsis. Individuals with renal failure and/or renal insufficiency. Patients with severe forms of developmental dysplasia of the hip (DDH): Crowe types II, III, IV.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Richard E Field, PhD FRCS(Orth)
Organizational Affiliation
British Orthopaedic Association
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Elective Orthopaedic Centre (EOC)
City
Epsom
ZIP/Postal Code
KT18 7EG
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

A Randomised Trial Comparing Anterior Versus Posterior Approach in Total Hip Replacement

We'll reach out to this number within 24 hrs